Cargando…

Safety and efficacy of maraviroc (MVC) combined with multiple different therapeutic agents in highly treatment-experienced (TE) patients in Brazil

Detalles Bibliográficos
Autores principales: Furtado, JJD, Madruga, JV, Bicudo, EL, Eira, M, Lopes, MIB, Netto, EM, de Oliveira, MS, Leite, OHM, Machado, AA, Tupinambas, U, de Andrade Neto, JL, Lima, MPJ, Wajsbrot, DB, Cassoli, LM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112879/
http://dx.doi.org/10.1186/1758-2652-13-S4-P105
_version_ 1782205838296875008
author Furtado, JJD
Madruga, JV
Bicudo, EL
Eira, M
Lopes, MIB
Netto, EM
de Oliveira, MS
Leite, OHM
Machado, AA
Tupinambas, U
de Andrade Neto, JL
Lima, MPJ
Wajsbrot, DB
Cassoli, LM
author_facet Furtado, JJD
Madruga, JV
Bicudo, EL
Eira, M
Lopes, MIB
Netto, EM
de Oliveira, MS
Leite, OHM
Machado, AA
Tupinambas, U
de Andrade Neto, JL
Lima, MPJ
Wajsbrot, DB
Cassoli, LM
author_sort Furtado, JJD
collection PubMed
description
format Online
Article
Text
id pubmed-3112879
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31128792011-06-13 Safety and efficacy of maraviroc (MVC) combined with multiple different therapeutic agents in highly treatment-experienced (TE) patients in Brazil Furtado, JJD Madruga, JV Bicudo, EL Eira, M Lopes, MIB Netto, EM de Oliveira, MS Leite, OHM Machado, AA Tupinambas, U de Andrade Neto, JL Lima, MPJ Wajsbrot, DB Cassoli, LM J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3112879/ http://dx.doi.org/10.1186/1758-2652-13-S4-P105 Text en Copyright ©2010 Cassoli et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Furtado, JJD
Madruga, JV
Bicudo, EL
Eira, M
Lopes, MIB
Netto, EM
de Oliveira, MS
Leite, OHM
Machado, AA
Tupinambas, U
de Andrade Neto, JL
Lima, MPJ
Wajsbrot, DB
Cassoli, LM
Safety and efficacy of maraviroc (MVC) combined with multiple different therapeutic agents in highly treatment-experienced (TE) patients in Brazil
title Safety and efficacy of maraviroc (MVC) combined with multiple different therapeutic agents in highly treatment-experienced (TE) patients in Brazil
title_full Safety and efficacy of maraviroc (MVC) combined with multiple different therapeutic agents in highly treatment-experienced (TE) patients in Brazil
title_fullStr Safety and efficacy of maraviroc (MVC) combined with multiple different therapeutic agents in highly treatment-experienced (TE) patients in Brazil
title_full_unstemmed Safety and efficacy of maraviroc (MVC) combined with multiple different therapeutic agents in highly treatment-experienced (TE) patients in Brazil
title_short Safety and efficacy of maraviroc (MVC) combined with multiple different therapeutic agents in highly treatment-experienced (TE) patients in Brazil
title_sort safety and efficacy of maraviroc (mvc) combined with multiple different therapeutic agents in highly treatment-experienced (te) patients in brazil
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112879/
http://dx.doi.org/10.1186/1758-2652-13-S4-P105
work_keys_str_mv AT furtadojjd safetyandefficacyofmaravirocmvccombinedwithmultipledifferenttherapeuticagentsinhighlytreatmentexperiencedtepatientsinbrazil
AT madrugajv safetyandefficacyofmaravirocmvccombinedwithmultipledifferenttherapeuticagentsinhighlytreatmentexperiencedtepatientsinbrazil
AT bicudoel safetyandefficacyofmaravirocmvccombinedwithmultipledifferenttherapeuticagentsinhighlytreatmentexperiencedtepatientsinbrazil
AT eiram safetyandefficacyofmaravirocmvccombinedwithmultipledifferenttherapeuticagentsinhighlytreatmentexperiencedtepatientsinbrazil
AT lopesmib safetyandefficacyofmaravirocmvccombinedwithmultipledifferenttherapeuticagentsinhighlytreatmentexperiencedtepatientsinbrazil
AT nettoem safetyandefficacyofmaravirocmvccombinedwithmultipledifferenttherapeuticagentsinhighlytreatmentexperiencedtepatientsinbrazil
AT deoliveirams safetyandefficacyofmaravirocmvccombinedwithmultipledifferenttherapeuticagentsinhighlytreatmentexperiencedtepatientsinbrazil
AT leiteohm safetyandefficacyofmaravirocmvccombinedwithmultipledifferenttherapeuticagentsinhighlytreatmentexperiencedtepatientsinbrazil
AT machadoaa safetyandefficacyofmaravirocmvccombinedwithmultipledifferenttherapeuticagentsinhighlytreatmentexperiencedtepatientsinbrazil
AT tupinambasu safetyandefficacyofmaravirocmvccombinedwithmultipledifferenttherapeuticagentsinhighlytreatmentexperiencedtepatientsinbrazil
AT deandradenetojl safetyandefficacyofmaravirocmvccombinedwithmultipledifferenttherapeuticagentsinhighlytreatmentexperiencedtepatientsinbrazil
AT limampj safetyandefficacyofmaravirocmvccombinedwithmultipledifferenttherapeuticagentsinhighlytreatmentexperiencedtepatientsinbrazil
AT wajsbrotdb safetyandefficacyofmaravirocmvccombinedwithmultipledifferenttherapeuticagentsinhighlytreatmentexperiencedtepatientsinbrazil
AT cassolilm safetyandefficacyofmaravirocmvccombinedwithmultipledifferenttherapeuticagentsinhighlytreatmentexperiencedtepatientsinbrazil